These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bacteriology of Mycobacterium leprae: state of the art paper. Draper P Ann Microbiol (Paris); 1982; 133(1):13-4. PubMed ID: 6810740 [No Abstract] [Full Text] [Related]
4. Prolongation of the lag phase of Mycobacterium leprae by dapsone. Levy L Proc Soc Exp Biol Med; 1972 Jan; 139(1):263-6. PubMed ID: 4550215 [No Abstract] [Full Text] [Related]
5. Committee 2: workshop on the microbiology of leprosy. Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):291-4. PubMed ID: 378875 [No Abstract] [Full Text] [Related]
7. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses. Browne SG Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048 [No Abstract] [Full Text] [Related]
8. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy. Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796 [TBL] [Abstract][Full Text] [Related]
9. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]
10. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report. Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722 [No Abstract] [Full Text] [Related]
11. Dapsone-resistant leprosy in a population of Bamako (Mali). Baquillon G; Ferracci C; Saint Andre P; Pattyn SR Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500 [No Abstract] [Full Text] [Related]
13. Does dapsone resistance really matter in the MDT era? Ji B Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322 [No Abstract] [Full Text] [Related]
14. Dapsone-resistant leprosy in Jakarta: a preliminary report. Utji R; Kosasih A; Santoso AU Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723 [No Abstract] [Full Text] [Related]
15. Prevalence of secondary dapsone-resistant leprosy in Upper Volta. Pattyn SR; Yada A; Sansarricq H; van Loo L Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476 [No Abstract] [Full Text] [Related]
16. Dapsone-resistant leprosy and its implications for leprosy control programmes. Pearson JM; Cap JA; Haile GS; Rees RJ Lepr Rev; 1977 Jun; 48(2):83-94. PubMed ID: 331000 [No Abstract] [Full Text] [Related]
17. Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae. McDougall AC; Rees RJ Lepr Rev; 1973 Jun; 44(2):59-64. PubMed ID: 4582180 [No Abstract] [Full Text] [Related]
18. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies. Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852 [No Abstract] [Full Text] [Related]
19. Rapid test for drug resistance in leprosy. Ambrose EJ; Khanolkar SR; Antia NH; Chulawalla RG; Koticha KK Lancet; 1977 Nov; 2(8046):1036. PubMed ID: 72940 [No Abstract] [Full Text] [Related]